vs
Side-by-side financial comparison of PEGASYSTEMS INC (PEGA) and Bio-Techne (TECH). Click either name above to swap in a different company.
PEGASYSTEMS INC is the larger business by last-quarter revenue ($430.0M vs $295.9M, roughly 1.5× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 7.6%, a 5.2% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -9.6%). Over the past eight quarters, PEGASYSTEMS INC's revenue compounded faster (10.7% CAGR vs 4.2%).
Pegasystems Inc. (Pega) is a global software company based in Waltham, Massachusetts, in the United States, and founded in 1983. The company has been publicly traded since 1996 as PEGA (NASDAQ). Pega is a low-code platform for workflow automation and generative AI-powered decision-making for businesses.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PEGA vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $430.0M | $295.9M |
| Net Profit | $32.8M | $38.0M |
| Gross Margin | 75.2% | 64.6% |
| Operating Margin | 8.6% | 18.4% |
| Net Margin | 7.6% | 12.8% |
| Revenue YoY | -9.6% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $0.18 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $430.0M | — | ||
| Q4 25 | $504.3M | $295.9M | ||
| Q3 25 | $381.4M | — | ||
| Q2 25 | $384.5M | $317.0M | ||
| Q1 25 | $475.6M | $316.2M | ||
| Q4 24 | $490.8M | $297.0M | ||
| Q3 24 | $325.1M | $289.5M | ||
| Q2 24 | $351.2M | $306.1M |
| Q1 26 | $32.8M | — | ||
| Q4 25 | $234.6M | $38.0M | ||
| Q3 25 | $43.4M | — | ||
| Q2 25 | $30.1M | $-17.7M | ||
| Q1 25 | $85.4M | $22.6M | ||
| Q4 24 | $119.1M | $34.9M | ||
| Q3 24 | $-14.4M | $33.6M | ||
| Q2 24 | $6.6M | $40.6M |
| Q1 26 | 75.2% | — | ||
| Q4 25 | 79.5% | 64.6% | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 71.5% | 62.7% | ||
| Q1 25 | 78.5% | 67.9% | ||
| Q4 24 | 79.1% | 65.3% | ||
| Q3 24 | 70.2% | 63.2% | ||
| Q2 24 | 72.4% | 66.4% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 20.7% | 18.4% | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 4.5% | -7.5% | ||
| Q1 25 | 26.7% | 12.2% | ||
| Q4 24 | 29.1% | 16.0% | ||
| Q3 24 | -3.6% | 13.8% | ||
| Q2 24 | 3.7% | 15.0% |
| Q1 26 | 7.6% | — | ||
| Q4 25 | 46.5% | 12.8% | ||
| Q3 25 | 11.4% | — | ||
| Q2 25 | 7.8% | -5.6% | ||
| Q1 25 | 18.0% | 7.1% | ||
| Q4 24 | 24.3% | 11.7% | ||
| Q3 24 | -4.4% | 11.6% | ||
| Q2 24 | 1.9% | 13.3% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $0.81 | $0.24 | ||
| Q3 25 | $0.24 | — | ||
| Q2 25 | $0.17 | $-0.11 | ||
| Q1 25 | $0.91 | $0.14 | ||
| Q4 24 | $1.35 | $0.22 | ||
| Q3 24 | $-0.17 | $0.21 | ||
| Q2 24 | $0.07 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $270.0M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $705.9M | $2.0B |
| Total Assets | $1.6B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $270.0M | — | ||
| Q4 25 | $425.8M | $172.9M | ||
| Q3 25 | $351.4M | — | ||
| Q2 25 | $411.6M | $162.2M | ||
| Q1 25 | $371.7M | $140.7M | ||
| Q4 24 | $740.0M | $177.5M | ||
| Q3 24 | $703.0M | $187.5M | ||
| Q2 24 | $665.1M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | $705.9M | — | ||
| Q4 25 | $787.4M | $2.0B | ||
| Q3 25 | $596.8M | — | ||
| Q2 25 | $624.5M | $1.9B | ||
| Q1 25 | $611.3M | $2.0B | ||
| Q4 24 | $585.5M | $2.1B | ||
| Q3 24 | $473.0M | $2.1B | ||
| Q2 24 | $435.4M | $2.1B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $2.5B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.8B | $2.7B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.5B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $206.5M | — |
| FCF MarginFCF / Revenue | 48.0% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $494.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.4M | — | ||
| Q3 25 | $56.3M | — | ||
| Q2 25 | $86.3M | $98.2M | ||
| Q1 25 | $204.2M | $41.1M | ||
| Q4 24 | $95.2M | $84.3M | ||
| Q3 24 | $30.5M | $63.9M | ||
| Q2 24 | $40.1M | $75.5M |
| Q1 26 | $206.5M | — | ||
| Q4 25 | $152.4M | — | ||
| Q3 25 | $51.8M | — | ||
| Q2 25 | $84.1M | $93.3M | ||
| Q1 25 | $202.3M | $31.0M | ||
| Q4 24 | $92.4M | $77.5M | ||
| Q3 24 | $27.4M | $54.7M | ||
| Q2 24 | $38.8M | $57.5M |
| Q1 26 | 48.0% | — | ||
| Q4 25 | 30.2% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 21.9% | 29.4% | ||
| Q1 25 | 42.5% | 9.8% | ||
| Q4 24 | 18.8% | 26.1% | ||
| Q3 24 | 8.4% | 18.9% | ||
| Q2 24 | 11.1% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.6% | 1.5% | ||
| Q1 25 | 0.4% | 3.2% | ||
| Q4 24 | 0.6% | 2.3% | ||
| Q3 24 | 0.9% | 3.2% | ||
| Q2 24 | 0.4% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.68× | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 2.87× | — | ||
| Q1 25 | 2.39× | 1.82× | ||
| Q4 24 | 0.80× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 6.06× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PEGA
| Pega Cloud | $205.0M | 48% |
| Subscription license | $94.9M | 22% |
| Maintenance | $75.3M | 18% |
| Consulting | $54.8M | 13% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
